Pfizer Inc. et al v. Apotex Inc. et al
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PBG Puerto Rico LLC and PF PRISM IMB B.V. |
Apotex Inc. and Apotex Corp. |
1:2023cv00445 |
April 21, 2023 |
U.S. District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on June 1, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 11 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (Attachments: #1 Notice of Dismissal)(kmd) |
Filing 10 NOTICE of Voluntary Dismissal by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc. (Dellinger, Megan) |
CASE CLOSED per #10 Notice of Dismissal. (kmd) |
Filing 9 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 8 WAIVER OF SERVICE returned executed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC: For Apotex Corp. waiver sent on 4/24/2023, answer due 6/23/2023. (Dellinger, Megan) |
Filing 7 WAIVER OF SERVICE returned executed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC: For Apotex Inc. waiver sent on 4/24/2023, answer due 6/23/2023. (Dellinger, Megan) |
Filing 6 Summons Issued as to Apotex Corp. and Apotex Inc. on 4/21/2023. (Attachments: #1 Summons Issued Apotex Inc.)(jfm) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V.; No Parents or Affiliates for Pfizer, Inc. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc. (jfm) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (jfm) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 8, 2023. Date of Expiration of Patent: December 8, 2025.Thirty Month Stay Deadline: September 8, 2025. (jfm) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
Filing 1 COMPLAINT filed against Apotex Corp. and Apotex Inc. (Filing fee $ 402, receipt number ADEDC-4118881.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PF PRISM IMB B.V., PBG Puerto Rico LLC. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.